Ackermans & van Haaren

Biotalys is an agricultural technology company based in Ghent, Belgium, founded in 2013. The company specializes in researching and developing biopesticides designed to control pests and diseases on crops and harvested products. Biotalys employs its proprietary Agrobody technology platform to create protein-based biocontrol solutions that combine the effectiveness of chemical pesticides with the safety profile of biologicals. These solutions are suitable for both pre- and post-harvest applications, aiming to provide a more sustainable and safer food supply. The company's technology platform generates products that enable targeted delivery and retention of active ingredients to prevent and control weeds, pests, and diseases.

Vico Therapeutics B.V. is a biotechnology company based in Leiden, the Netherlands, founded in 2019. The company specializes in the development of RNA modulating therapies aimed at treating rare neurological disorders. Vico Therapeutics focuses on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome, which encompass a range of hereditary and neurodevelopmental disorders. By discovering and developing innovative therapies, the company aims to address significant unmet medical needs in the central nervous system, providing new treatment options for patients and healthcare professionals.

Vico Therapeutics B.V. is a biotechnology company based in Leiden, the Netherlands, founded in 2019. The company specializes in the development of RNA modulating therapies aimed at treating rare neurological disorders. Vico Therapeutics focuses on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome, which encompass a range of hereditary and neurodevelopmental disorders. By discovering and developing innovative therapies, the company aims to address significant unmet medical needs in the central nervous system, providing new treatment options for patients and healthcare professionals.

Camlin Fine Sciences Limited is a Mumbai-based company engaged in the research, development, manufacturing, and marketing of specialty chemicals and additive products. With a global presence, it operates in markets across India, Mexico, North America, Europe, and Asia. The company specializes in providing shelf-life extension solutions, which include antioxidants and natural products aimed at enhancing the longevity of food and feed. Its portfolio includes aroma ingredients like vanillin and ethyl vanillin, as well as nutraceutical products derived from fermentation and green extraction sources. Camlin Fine Sciences also produces performance chemicals and various animal nutrition products, such as growth promoters and antimicrobials. The products cater to diverse industries, including food and beverage, agriculture, pharmaceuticals, and petrochemicals. Founded in 1931, the company was previously known as Camlin Fine Chemicals and rebranded in 2011 to reflect its broader focus on specialty chemicals.

AstriVax is a biotechnology company focused on developing innovative vaccines that address significant challenges in the field of vaccinology. The company aims to achieve initial clinical validation of its platform technology, which is designed to create a diverse pipeline of vaccines. AstriVax's vaccine candidates are engineered to minimize cold chain requirements, making them more accessible and easier to distribute. Additionally, these vaccines are intended to provide broad and long-lasting protection against a variety of viruses and pathogens, thereby enhancing treatment options within the healthcare sector.

Medikabazaar is an online B2B marketplace dedicated to the procurement of medical supplies and equipment. It serves as a centralized platform for medical institutions and individual practitioners, helping them reduce operational costs while providing access to a wide range of global brands. The company connects with over 50,000 medical establishments and 150,000 independent practitioners across India, partnering with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. Medikabazaar utilizes technology to streamline the procurement process in a complex market, featuring a voice-based search engine and an online payment portal for user convenience. Its efficient last-mile delivery system, supported by 26 strategically located fulfillment centers, ensures timely delivery of essential medical supplies, thereby enhancing the quality of patient care across diverse healthcare facilities.

Medikabazaar is an online B2B marketplace dedicated to the procurement of medical supplies and equipment. It serves as a centralized platform for medical institutions and individual practitioners, helping them reduce operational costs while providing access to a wide range of global brands. The company connects with over 50,000 medical establishments and 150,000 independent practitioners across India, partnering with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. Medikabazaar utilizes technology to streamline the procurement process in a complex market, featuring a voice-based search engine and an online payment portal for user convenience. Its efficient last-mile delivery system, supported by 26 strategically located fulfillment centers, ensures timely delivery of essential medical supplies, thereby enhancing the quality of patient care across diverse healthcare facilities.

Medikabazaar is an online B2B marketplace dedicated to the procurement of medical supplies and equipment. It serves as a centralized platform for medical institutions and individual practitioners, helping them reduce operational costs while providing access to a wide range of global brands. The company connects with over 50,000 medical establishments and 150,000 independent practitioners across India, partnering with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. Medikabazaar utilizes technology to streamline the procurement process in a complex market, featuring a voice-based search engine and an online payment portal for user convenience. Its efficient last-mile delivery system, supported by 26 strategically located fulfillment centers, ensures timely delivery of essential medical supplies, thereby enhancing the quality of patient care across diverse healthcare facilities.

MRM Health NV is a biopharmaceutical company based in Ghent, Belgium, specializing in the development of microbiome-based therapeutics aimed at treating metabolic diseases. Founded in early 2020 as a subsidiary of MRM Technologies N.V., the company focuses on innovative drug discovery, notably its lead candidate MH002, which targets Inflammatory Bowel Disease (IBD), encompassing conditions such as Ulcerative Colitis and Crohn's disease. MRM Health was established in collaboration with the Flemish Institute of Biotechnology, leveraging expertise in microbiome research to translate scientific discoveries into effective therapeutic applications.

OncoDNA is a theranostic and genomic company that specializes in precision medicine for cancer and genetic diseases. Founded by a team with over 60 years of experience in medical diagnostics, the company focuses on providing clinical guidance for the treatment and real-time monitoring of late-stage cancer patients. OncoDNA supports researchers and biopharma companies in navigating the complexities of molecular biology, facilitating research and drug development in oncology. With its commitment to delivering precision medicine, OncoDNA aims to enhance treatment outcomes and improve the management of cancer and genetic disorders.

Medikabazaar is an online B2B marketplace dedicated to the procurement of medical supplies and equipment. It serves as a centralized platform for medical institutions and individual practitioners, helping them reduce operational costs while providing access to a wide range of global brands. The company connects with over 50,000 medical establishments and 150,000 independent practitioners across India, partnering with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. Medikabazaar utilizes technology to streamline the procurement process in a complex market, featuring a voice-based search engine and an online payment portal for user convenience. Its efficient last-mile delivery system, supported by 26 strategically located fulfillment centers, ensures timely delivery of essential medical supplies, thereby enhancing the quality of patient care across diverse healthcare facilities.

Biotalys is an agricultural technology company based in Ghent, Belgium, founded in 2013. The company specializes in researching and developing biopesticides designed to control pests and diseases on crops and harvested products. Biotalys employs its proprietary Agrobody technology platform to create protein-based biocontrol solutions that combine the effectiveness of chemical pesticides with the safety profile of biologicals. These solutions are suitable for both pre- and post-harvest applications, aiming to provide a more sustainable and safer food supply. The company's technology platform generates products that enable targeted delivery and retention of active ingredients to prevent and control weeds, pests, and diseases.

Biolectric is a developer of biogas installation systems aimed at enhancing the biogas energy production sector. The company specializes in a process that converts organic material into biogas under anaerobic conditions, effectively utilizing available resources without the need for additional organic waste. This innovative approach allows clients to lower energy production costs while promoting environmentally friendly energy solutions. By providing a reliable method for renewable energy generation, Biolectric addresses the challenge of matching energy supply with demand and contributes to the advancement of sustainable energy practices.

OncoDNA is a theranostic and genomic company that specializes in precision medicine for cancer and genetic diseases. Founded by a team with over 60 years of experience in medical diagnostics, the company focuses on providing clinical guidance for the treatment and real-time monitoring of late-stage cancer patients. OncoDNA supports researchers and biopharma companies in navigating the complexities of molecular biology, facilitating research and drug development in oncology. With its commitment to delivering precision medicine, OncoDNA aims to enhance treatment outcomes and improve the management of cancer and genetic disorders.